These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 95340)

  • 21. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
    Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
    IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between hepatitis B virus infection and hepatic cell carcinoma in Mozambique.
    Reys LL; Purcell RH; Holland PV; Alter HJ
    Trop Geogr Med; 1977 Sep; 29(3):251-6. PubMed ID: 202048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis and hepatocellular carcinoma].
    Ichida F
    Gan No Rinsho; 1983 May; 29(6):469-73. PubMed ID: 6308305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology of liver cirrhosis and hepatocellular carcinoma. Recent studies by Japanese workers.
    Mori W; Machinami R
    Acta Pathol Jpn; 1982; 32 Suppl 1():133-43. PubMed ID: 6196936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of hepatitis Bs antigen titres and alpha foetoprotein levels in primary hepatocellular carcinoma in Kenya.
    Bowry TR; Shah MV
    East Afr Med J; 1980 Jun; 57(6):382--9. PubMed ID: 6156817
    [No Abstract]   [Full Text] [Related]  

  • 29. HLA antigen in Chinese patients with hepatocellular carcinomas.
    Chan SH; Simons MJ; Oon CJ
    J Natl Cancer Inst; 1980 Jul; 65(1):21-3. PubMed ID: 6156260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
    Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B
    Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
    Wang WL
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
    [No Abstract]   [Full Text] [Related]  

  • 32. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
    Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
    Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis Bs antigen in primary liver cancer].
    Kunchev K
    Vutr Boles; 1978; 17(2):24-7. PubMed ID: 207025
    [No Abstract]   [Full Text] [Related]  

  • 34. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.
    Kew MC; Gear AJ; Baumgarten I; Dusheiko GM; Maier G
    Gastroenterology; 1979 Sep; 77(3):537-9. PubMed ID: 222645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis B virus infection and hepatocellular carcinoma: indication for a possible causal connection even in non-endemic Switzerland].
    Pirovino M; Heer M; Altorfer J; Akovbiantz A; Grob P; Schmid M
    Schweiz Med Wochenschr; 1983 Jun; 113(22):824-6. PubMed ID: 6192495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled study of hepatitis core antibody (HBcAb) in primary hepatocellular carcinoma and liver cirrhosis in Kenya.
    Bowry TR; Shah MV; Ahmad Z
    East Afr Med J; 1981 Aug; 58(8):576-82. PubMed ID: 6271520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.